By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Blaze Bioscience Inc. 

P.O. Box 61323

Seattle  Washington   98141-6323  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Diagnostics






Company News
Blaze Bioscience Inc. Announces Open Enrollment For Phase 1 Clinical Trial Of Tumor Paint BLZ-100 In Patients With Solid Tumor Cancers 7/14/2015 9:42:57 AM
Blaze Bioscience Inc.’s BLZ-100 Receives Orphan Drug Designation From FDA For Brain Cancer 7/7/2015 10:34:34 AM
Blaze Bioscience Inc. Announces Open Enrollment For Phase 1 Clinical Trial Of Tumor Paint BLZ-100 In Children With Brain Cancer 6/4/2015 9:17:11 AM
Blaze Bioscience Inc. Announces Poster Presentation At ASCO 2015 Annual Meeting 5/27/2015 11:11:16 AM
Blaze Bioscience Inc. Appoints Jan Öhrström, M.D., To Its Board Of Directors 4/1/2015 12:26:27 PM
Blaze Bioscience Inc. Announces Poster Presentation At The American Academy of Dermatology 73rd Annual Meeting 3/18/2015 10:14:21 AM
Blaze Bioscience Inc. Announces National Cancer Institute SBIR Phase II Funding For Clinical Trial Of Tumor Paint™ BLZ-100 In Sarcoma 10/8/2014 10:10:04 AM
Blaze Bioscience Inc. Announces Initiation Of Phase 1b Brain Cancer Program For Tumor PaintTM BLZ-100 9/25/2014 11:32:39 AM
Blaze Bioscience Inc. Announces Presentation At The 2014 Wedbush Pacgrow Life Sciences Management Access Conference 8/13/2014 8:02:52 AM
Blaze Bioscience Inc. Announces Initiation Of First-In-Human Phase 1 Clinical Study Of BLZ-100 12/19/2013 9:45:40 AM
12
//-->